Growing community of inventors

Zomergem, Belgium

Wouter Louis J Couck

Average Co-Inventor Count = 6.18

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Wouter Louis J CouckAndras Horvath (2 patents)Wouter Louis J CouckDominique Paul Michel Depré (2 patents)Wouter Louis J CouckStijn Wuyts (2 patents)Wouter Louis J CouckJozef Ludo Jan Cuypers (2 patents)Wouter Louis J CouckSyuzanna Harutyunyan (2 patents)Wouter Louis J CouckGregory Fabien Sebastian Binot (2 patents)Wouter Louis J CouckAlex Herman Copmans (1 patent)Wouter Louis J CouckJoannes Petrus Van Dun (1 patent)Wouter Louis J CouckJérôme Albert Joseph Hoet (1 patent)Wouter Louis J CouckAlbert Louis Anna Willemsens (1 patent)Wouter Louis J CouckDominique Paul Michel DeprÉ (0 patent)Wouter Louis J CouckGregory Fabien Sebastien Binot (0 patent)Wouter Louis J CouckWouter Louis J Couck (3 patents)Andras HorvathAndras Horvath (17 patents)Dominique Paul Michel DepréDominique Paul Michel Depré (8 patents)Stijn WuytsStijn Wuyts (4 patents)Jozef Ludo Jan CuypersJozef Ludo Jan Cuypers (3 patents)Syuzanna HarutyunyanSyuzanna Harutyunyan (2 patents)Gregory Fabien Sebastian BinotGregory Fabien Sebastian Binot (2 patents)Alex Herman CopmansAlex Herman Copmans (14 patents)Joannes Petrus Van DunJoannes Petrus Van Dun (2 patents)Jérôme Albert Joseph HoetJérôme Albert Joseph Hoet (1 patent)Albert Louis Anna WillemsensAlbert Louis Anna Willemsens (1 patent)Dominique Paul Michel DeprÉDominique Paul Michel DeprÉ (0 patent)Gregory Fabien Sebastien BinotGregory Fabien Sebastien Binot (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Pharmaceuticals, Inc. (2 from 159 patents)

2. Janssen Pharmaceutica Nv (1 from 2,076 patents)


3 patents:

1. 9328108 - Process for preparing an intermediate of the macrocyclic protease inhibitor TMC 435

2. 8981082 - Process for preparing an intermediate of the macrocyclic protease inhibitor TMC 435

3. 8461341 - Resolution of (±)-methyl phenyl[4-[4-[[[4'(trifluoromethyl)-2-biphenylyl]carbonyl]amino]Phenyl]-1-piperidinyl]acetate

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…